Literature DB >> 8322232

Reduced carbon monoxide transfer factor (TLCO) in human immunodeficiency virus type I (HIV-I) infection as a predictor for faster progression to AIDS.

R B Nieman1, J Fleming, R J Coker, J R Harris, D M Mitchell.   

Abstract

BACKGROUND: In addition to the acute fall in carbon monoxide transfer factor (TLCO) associated with Pneumocystis carinii pneumonia (PCP) or other opportunistic lung infections, reduced TLCO occurs in HIV-I seropositive individuals without active pulmonary disease. Abnormal TLCO, in the absence of lung disease, may be a surrogate marker of HIV-I induced immunosuppression and, therefore, a predictor for a more rapid progression to AIDS.
METHODS: Eighty four individuals with AIDS, who had regular pulmonary function tests before the diagnosis of AIDS was made, were identified from a cohort of patients with HIV-I infection. None had evidence of active pulmonary disease at the time of initial pulmonary function testing. The relation between the time taken to progress to AIDS and initial pulmonary function tests was examined with life table survival analysis.
RESULTS: Patients with a TLCO value of < 80% of predicted normal (n = 46) progressed significantly faster to AIDS, with a median time of 8.0 months compared with 16.5 months for those with a TLCO value of > or = 80% (n = 38). When stratified by AIDS defining diagnosis (PCP or non-PCP), median time to PCP was also significantly related to initial TLCO values (TLCO of < 80% = 9.0 months, TLCO of > or = 80% = 19.0 months). Reductions in other measurements of lung function (FEV1, FVC, KCO) were not temporally associated with the development of AIDS.
CONCLUSIONS: HIV-I seropositive individuals with TLCO values of < 80% predicted and no evidence of lung disease progress more rapidly to AIDS than those with TLCO values of > or = 80%.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8322232      PMCID: PMC464497          DOI: 10.1136/thx.48.5.481

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  20 in total

Review 1.  AIDS and the lung. 4-- Non-invasive investigation of pulmonary disease in patients positive for the human immunodeficiency virus.

Authors:  A B Millar; D M Mitchell
Journal:  Thorax       Date:  1990-01       Impact factor: 9.139

Review 2.  AIDS and the lung. 5--Tests giving an aetiological diagnosis in pulmonary disease in patients infected with the human immunodeficiency virus.

Authors:  R F Miller; T R Leigh; J V Collins; D M Mitchell
Journal:  Thorax       Date:  1990-01       Impact factor: 9.139

3.  Predicted values: how should we use them?

Authors:  J E Cotes
Journal:  Thorax       Date:  1989-03       Impact factor: 9.139

Review 4.  Pulmonary function tests.

Authors:  D E Stover; G U Meduri
Journal:  Clin Chest Med       Date:  1988-09       Impact factor: 2.878

5.  Human immunodeficiency virus-related lymphocytic alveolitis.

Authors:  J M Guillon; B Autran; M Denis; P Fouret; F Plata; C M Mayaud; G M Akoun
Journal:  Chest       Date:  1988-12       Impact factor: 9.410

6.  Lung function abnormalities in patients infected with the human immunodeficiency virus with and without overt pneumonitis.

Authors:  R J Shaw; C Roussak; S M Forster; J R Harris; A J Pinching; D M Mitchell
Journal:  Thorax       Date:  1988-06       Impact factor: 9.139

7.  Correlation between serial pulmonary function tests and fiberoptic bronchoscopy in patients with Pneumocystis carinii pneumonia and the acquired immune deficiency syndrome.

Authors:  D L Coleman; P M Dodek; J A Golden; J M Luce; E Golden; W M Gold; J F Murray
Journal:  Am Rev Respir Dis       Date:  1984-03

8.  Nonspecific interstitial pneumonitis: a common cause of pulmonary disease in the acquired immunodeficiency syndrome.

Authors:  A F Suffredini; F P Ognibene; E E Lack; J T Simmons; M Brenner; V J Gill; H C Lane; A S Fauci; J E Parrillo; H Masur
Journal:  Ann Intern Med       Date:  1987-07       Impact factor: 25.391

9.  Alveolar-capillary block in patients with AIDS and Pneumocystis carinii pneumonia.

Authors:  R M Sankary; J Turner; A Lipavsky; E L Howes; J F Murray
Journal:  Am Rev Respir Dis       Date:  1988-02

10.  Detection of Pneumocystis carinii with DNA amplification.

Authors:  A E Wakefield; F J Pixley; S Banerji; K Sinclair; R F Miller; E R Moxon; J M Hopkin
Journal:  Lancet       Date:  1990-08-25       Impact factor: 79.321

View more
  8 in total

1.  Pulmonary function abnormalities in HIV-infected patients during the current antiretroviral therapy era.

Authors:  Matthew R Gingo; M Patricia George; Cathy J Kessinger; Lorrie Lucht; Barbara Rissler; Renee Weinman; William A Slivka; Deborah K McMahon; Sally E Wenzel; Frank C Sciurba; Alison Morris
Journal:  Am J Respir Crit Care Med       Date:  2010-06-03       Impact factor: 21.405

2.  Does analysis of bronchoalveolar lavage fluid provide a tool to monitor disease progression or to predict survival in patients with HIV-1 infection?

Authors:  C Agostini; G Semenzato
Journal:  Thorax       Date:  1994-09       Impact factor: 9.139

Review 3.  Cigarette smoking in the HIV-infected population.

Authors:  Shiva Rahmanian; Mary Ellen Wewers; Susan Koletar; Nancy Reynolds; Amy Ferketich; Philip Diaz
Journal:  Proc Am Thorac Soc       Date:  2011-06

4.  Contributors to diffusion impairment in HIV-infected persons.

Authors:  Matthew R Gingo; Jiayan He; Catherine Wittman; Carl Fuhrman; Joseph K Leader; Cathy Kessinger; Lorrie Lucht; William A Slivka; Yingze Zhang; Deborah K McMahon; Frank C Sciurba; Alison Morris
Journal:  Eur Respir J       Date:  2013-02-21       Impact factor: 16.671

Review 5.  Human immunodeficiency virus-associated obstructive lung diseases.

Authors:  Matthew R Gingo; Alison Morris; Kristina Crothers
Journal:  Clin Chest Med       Date:  2013-04-08       Impact factor: 2.878

Review 6.  HIV-associated obstructive lung diseases: insights and implications for the clinician.

Authors:  M Bradley Drummond; Gregory D Kirk
Journal:  Lancet Respir Med       Date:  2014-05-13       Impact factor: 30.700

Review 7.  Chronic obstructive pulmonary disease in HIV.

Authors:  Katerina Byanova; Ken M Kunisaki; Joshua Vasquez; Laurence Huang
Journal:  Expert Rev Respir Med       Date:  2020-11-23       Impact factor: 3.772

Review 8.  Interactions between HIV infection and chronic obstructive pulmonary disease: Clinical and epidemiological aspects.

Authors:  Christine Raynaud; Nicolas Roche; Christos Chouaid
Journal:  Respir Res       Date:  2011-09-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.